首页> 外文期刊>Psychopharmacology >Rewarding and locomotor-activating effects of direct dopamine receptor agonists are augmented by chronic food restriction in rats
【24h】

Rewarding and locomotor-activating effects of direct dopamine receptor agonists are augmented by chronic food restriction in rats

机译:长期食物限制大鼠增强了直接多巴胺受体激动剂的奖励和运动激活作用

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Rationale: Previous studies indicate that chronic food restriction augments the rewarding and motor-activating effects of diverse drugs of abuse. The drugs that have so far proved susceptible to the augmenting effect of food restriction all increase synaptic concentrations of dopamine (DA). It is not known whether behavioral effects of selective, direct DA receptor agonists are also subject to the augmenting effect of food restriction. Objectives: The first objective of this study was to investigate whether the rewarding and locomotor-activating effects of the D1 agonist, A77636, and the D2 agonist, quinpirole are augmented by chronic food restriction. The second purpose was to investigate whether the augmented rewarding and locomotor-activating effects of d-amphetamine in food-restricted rats are reversed by the D1 antagonist, SCH23390. Methods: Rewarding effects of drugs were measured in terms of their ability to lower the threshold for lateral hypothalamic self-stimulation (LHSS) using a rate-frequency method. Locomotor-activating effects were measured in terms of the number of midline crossings exhibited by rats in a shuttle apparatus. Results: A77636 (1.0 and 2.5 mg/kg, i.p.) produced a greater threshold-lowering effect in food-restricted than ad libitum fed rats but produced variable effects on locomotor activity with no difference between groups. Quinpirole (0.2 and 0.5 mg/kg, i.p.) produced a marginally greater threshold-lowering effect in food-restricted rats and a dramatic locomotor response that was exclusive to food-restricted rats. The D1 antagonist, SCH23390, at a dose of 0.01 mg/kg (i.p.), had no effect on the lowering of LHSS threshold by amphetamine (0.5 mg/kg, i.p.) in ad libitum fed rats but blocked the augmentation otherwise observed in food-restricted rats. SCH23390, at a dose of 0.025 mg/kg, had no effect on locomotor activity induced by amphetamine (0.5 mg/kg) in ad libitum fed rats but blocked the augmentation otherwise observed in food-restricted rats. Conclusions: These results indicate that the augmentation of reward by food restriction extends to drugs that bypass the DA terminal and act postsynaptically. When taken together with prior immunohistochemical and behavioral findings, these results suggest that food restriction may increase the "enabling" effect of the D1 receptor on DA-mediated behaviors.
机译:理由:先前的研究表明,长期的食物限制会增加各种滥用药物的奖励和运动激活作用。迄今为止,已证明这些药物容易受到食物限制的增强作用,它们均会增加多巴胺(DA)的突触浓度。尚不知道选择性直接DA受体激动剂的行为作用是否也受到食物限制的增强作用。目的:本研究的第一个目的是研究慢性食物限制是否能增强D1 激动剂A77636和D2 激动剂喹吡罗的奖励和运动激活作用。第二个目的是研究D1 拮抗剂SCH23390是否能逆转d-苯异丙胺在食物限制型大鼠中增强的奖励和运动激活作用。方法:采用速率-频率法,通过降低药物降低下丘脑外侧自我刺激(LHSS)阈值的能力来衡量药物的奖励效果。通过在穿梭装置中大鼠表现出的中线交叉数来测量运动激活作用。结果:A77636(1.0和2.5 mg / kg,腹腔注射)在食物限制条件下的阈值降低作用大于自由喂养的大鼠,但对运动能力产生不同的影响,两组之间无差异。喹吡罗(0.2和0.5 mg / kg,腹腔内)在食物受限的大鼠中产生的阈值降低作用略高,而饮食受限的大鼠则具有明显的运动反应。 D1 拮抗剂SCH23390的剂量为0.01 mg / kg(ip),对随意喂养的大鼠苯丙胺(0.5 mg / kg,ip)降低LHSS阈值没有影响,但阻止了其增强否则在饮食受限的大鼠中观察到。 SCH23390的剂量为0.025 mg / kg,对随意喂养的大鼠的苯丙胺(0.5 mg / kg)诱导的运动活性没有影响,但阻止了在食物受限的大鼠中观察到的增强。结论:这些结果表明,通过食物限制来增加奖励的范围扩展到绕过DA末端并突触后起作用的药物。结合先前的免疫组织化学和行为学发现,这些结果表明食物限制可能会增加D1 受体对DA介导的行为的“促成”作用。

著录项

  • 来源
    《Psychopharmacology》 |2001年第4期|420-428|共9页
  • 作者单位

    Millhauser Laboratories Department of Psychiatry New York University School of Medicine 550 First Avenue New York NY 10016 USA;

    Millhauser Laboratories Department of Psychiatry New York University School of Medicine 550 First Avenue New York NY 10016 USA;

    Millhauser Laboratories Department of Psychiatry New York University School of Medicine 550 First Avenue New York NY 10016 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Food restriction Reward Locomotion Dopamine receptor A77636 Quinpirole;

    机译:食物限制奖励运动多巴胺受体A77636喹吡罗;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号